Back to homepage

Tag "disease-modifying antirheumatic drugs"

Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases

Authors: Valeria Nucera MD, Elisabetta Gerratana MD, Manuela Giallanza MD, Laura La Corte MD, Donatella Sangari MD, Fabiola Atzeni MD, PhD

This review focuses on cyclophosphamide due to its crucial role in the treatment of systemic sclerosis-related interstitial lung disease, particularly in the case of patients with progressive Interstitial lung diseases.